Nanobiotix S.A. (NBTX) — 6-K Filings

All 6-K filings from Nanobiotix S.A.. Browse 49 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (49)

Nanobiotix Files 6-K Report — Apr 20, 2026 Risk: low
Nanobiotix S.A. filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The company'
Nanobiotix Files 6-K Report with Press Release — Mar 30, 2026 Risk: medium
Nanobiotix S.A. filed a Form 6-K on March 30, 2026, reporting its activities as a foreign issuer. The filing includes a press release as Exhibit 99.1, detailing
Nanobiotix Files Routine 6-K Report on March 25, 2026 — Mar 25, 2026
This 6-K filing from Nanobiotix S.A. on March 25, 2026, is a routine report by a foreign issuer, indicating no new material financial or operational news. It in
Nanobiotix Files Routine 6-K Report — Dec 17, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on December 17, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal
6-K Filing — Dec 15, 2025
Nanobiotix Files 6-K for Managerial Transactions — Dec 1, 2025 Risk: low
On December 1, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. This filing serves as a notif
6-K Filing — Nov 24, 2025
6-K Filing — Nov 14, 2025
Nanobiotix Files 6-K for November 2025 — Nov 12, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on November 12, 2025, reporting for the month of November 2025. The company, a foreign private issuer, is based in Paris, Franc
6-K Filing — Nov 3, 2025
6-K Filing — Oct 31, 2025
Nanobiotix Files 6-K, Confirms 20-F Reporting — Oct 24, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on October 24, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal e
Nanobiotix Files October 2025 Report (6-K) — Oct 15, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on October 15, 2025, to report its activities for the month of October 2025. The company, a pharmaceutical preparations firm, i
Nanobiotix Files October 2025 6-K Report — Oct 1, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on October 1, 2025, reporting for the month of October 2025. The company, a pharmaceutical preparations firm, is based in Paris
Nanobiotix Files September 2025 6-K Report — Sep 30, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on September 30, 2025, for the month of September 2025. The filing is a report of a foreign private issuer and indicates that t
Nanobiotix Files 6-K with H1 2025 Financials — Sep 30, 2025 Risk: medium
Nanobiotix S.A. filed a 6-K report for the period ending June 30, 2025. The filing includes financial data for the first six months of 2025 and the full year 20
Nanobiotix Files September 2025 6-K Report — Sep 17, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on September 17, 2025, to report its activities for the month of September 2025. The company, based in Paris, France, is a phar
Nanobiotix Files Routine 6-K Report — Sep 12, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on September 12, 2025, to report information for the month of September 2025. The company, based in Paris, France, is a pharmac
Nanobiotix Files 6-K with SEC — Sep 2, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on September 2, 2025, reporting its status as a foreign private issuer. The company, based in Paris, France, is subject to the
Nanobiotix Files August 2025 6-K Report — Aug 27, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on August 27, 2025, reporting its activities for the month of August 2025. The company, a foreign private issuer, is based in P
Nanobiotix Files July 2025 6-K Report — Jul 11, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on July 11, 2025, reporting for the month of July 2025. The company, a foreign private issuer, is based in Paris, France, and o
Nanobiotix Grants 33,354 Free Shares to HR Director — Jul 2, 2025 Risk: low
On June 27, 2025, Nanobiotix S.A. reported a grant of 33,354 free shares to Anne-Juliette Hermant, the Human Resources Director. This transaction was an initial
Nanobiotix Files June 2025 Report on Form 6-K — Jun 10, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on June 10, 2025, reporting its activities for the month of June 2025. The company, a foreign private issuer, is based in Paris
Nanobiotix Files Routine 6-K Report — May 28, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on May 28, 2025, to report its activities for the month of May 2025. The company, based in Paris, France, is a foreign private
Nanobiotix Files 6-K on Insider Transactions — May 27, 2025 Risk: low
On May 27, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing serves as a notificati
Nanobiotix Files Routine 6-K Report — May 21, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on May 21, 2025, to report its activities for the month of May 2025. The company, based in Paris, France, is a foreign private
Nanobiotix Discloses Insider Transactions — May 15, 2025 Risk: low
On May 15, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing serves as a notificati
Nanobiotix Files 6-K Report — May 14, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on May 14, 2025, reporting its status as a foreign private issuer. The company, based in Paris, France, is registered with the
Nanobiotix Files Routine 6-K Disclosure — May 12, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on May 12, 2025, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing does not co
Nanobiotix Files May 2025 Report on Form 6-K — May 5, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on May 5, 2025, to report its activities for the month of May 2025. The company, a pharmaceutical preparations firm, is based i
Nanobiotix Files Routine 6-K Disclosure — Apr 30, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on April 30, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal exe
Nanobiotix Files Routine 6-K Report — Apr 14, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on April 14, 2025, reporting its status as a foreign private issuer. The company, incorporated in France with its principal exe
Nanobiotix Files 6-K on Insider Transactions — Apr 14, 2025 Risk: low
On April 14, 2025, Nanobiotix S.A. filed a Form 6-K to disclose transactions by persons discharging managerial responsibilities. The filing pertains to the mont
Nanobiotix S.A. Discloses Managerial Transactions — Apr 10, 2025 Risk: low
On April 10, 2025, Nanobiotix S.A. disclosed transactions by individuals in managerial positions. The filing, a Form 6-K, was made for the month of December 202
Nanobiotix Files April 2025 6-K Report — Apr 2, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on April 2, 2025, to report its activities for the month of April 2025. The company, a foreign private issuer, is based in Pari
Nanobiotix Files March 2025 6-K Report — Mar 31, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on March 31, 2025, for the month of March 2025. The company, incorporated in France with its principal executive office in Pari
Nanobiotix Files March 2025 6-K Report — Mar 27, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on March 27, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a pharmaceutic
Nanobiotix Files March 2025 6-K Report — Mar 20, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on March 20, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a foreign priv
Nanobiotix Files March 2025 6-K Report — Mar 17, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on March 17, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a pharmaceutic
Nanobiotix Files Routine 6-K Report — Mar 13, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on March 13, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a foreign priv
Nanobiotix Files February 2025 6-K Report — Feb 12, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on February 12, 2025, to report its activities for the month of February 2025. The company, a foreign private issuer, is based
Nanobiotix Files Routine 6-K Disclosure — Jan 29, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on January 29, 2025, to report its status as a foreign private issuer. The company, based in Paris, France, is required to file
Nanobiotix Files January 2025 6-K Report — Jan 21, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on January 21, 2025, reporting for the month of January 2025. The company, based in Paris, France, is a pharmaceutical preparat
Nanobiotix Files January 2025 6-K Report — Jan 10, 2025 Risk: low
Nanobiotix S.A. filed a Form 6-K on January 10, 2025, for the month of January 2025. The company, headquartered in Paris, France, is a foreign private issuer an
Nanobiotix Files Form 6-K for December 2024 — Dec 17, 2024 Risk: low
Nanobiotix S.A. filed a Form 6-K on December 17, 2024, to report information for the month of December 2024. The company, based in Paris, France, is a pharmaceu
Nanobiotix Discloses Insider Transactions — Dec 16, 2024 Risk: low
On December 16, 2024, Nanobiotix S.A. disclosed transactions by individuals in managerial positions. The filing, a Form 6-K, serves as a report of a foreign pri
Nanobiotix S.A. Reports Managerial Transactions — Dec 12, 2024 Risk: low
On December 12, 2024, Nanobiotix S.A. filed a Form 6-K to report transactions by individuals in managerial positions. The filing is a routine disclosure for for
Nanobiotix Files Routine 6-K Report — Dec 11, 2024 Risk: low
Nanobiotix S.A. filed a Form 6-K on December 11, 2024, to report information for the month of December 2024. The company, based in Paris, France, is a pharmaceu
Nanobiotix Files Routine 6-K Report — Dec 9, 2024 Risk: low
Nanobiotix S.A. filed a Form 6-K on December 9, 2024, reporting for the month of December 2024. The company, based in Paris, France, is a foreign private issuer

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX